nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An integrated view of liver injury and disease progression in nonalcoholic steatohepatitis
|
Sanyal, Arun J. |
|
2014 |
7 |
supplement-2 |
p. 800-805 |
artikel |
2 |
Current histological classification of NAFLD: strength and limitations
|
Bedossa, Pierre |
|
2014 |
7 |
supplement-2 |
p. 765-770 |
artikel |
3 |
Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
|
Duseja, Ajay |
|
2014 |
7 |
supplement-2 |
p. 755-764 |
artikel |
4 |
Hard clinical outcomes in patients with NAFLD
|
Kumar, Ramesh |
|
2014 |
7 |
supplement-2 |
p. 790-799 |
artikel |
5 |
Immune and inflammatory pathways in NASH
|
Ganz, Michal |
|
2014 |
7 |
supplement-2 |
p. 771-781 |
artikel |
6 |
Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH
|
Montesi, Luca |
|
2014 |
7 |
supplement-2 |
p. 814-822 |
artikel |
7 |
Insulin resistance, steatosis and hepatitis C virus
|
Mangia, Alessandra |
|
2014 |
7 |
supplement-2 |
p. 782-789 |
artikel |
8 |
Lean NASH: distinctiveness and clinical implication
|
Das, Kausik |
|
2014 |
7 |
supplement-2 |
p. 806-813 |
artikel |
9 |
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific
|
Vongsuvanh, Roslyn |
|
2014 |
7 |
supplement-2 |
p. 823-832 |
artikel |
10 |
Pharmacological agents for nonalcoholic steatohepatitis
|
Guillaume, Maeva |
|
2014 |
7 |
supplement-2 |
p. 833-841 |
artikel |